Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a retrospective study of patients with spasticity in the Spanish population.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All Participants | This was a retrospective chart review in patients with spasticity in the Spanish population. There was no treatment in this study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No treatment | Other | There was no treatment in this study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Physician Assessment of Spasticity | The physician assessed spasticity as per local standard practice. Not enough data was collected for analysis of this outcome measure. | Baseline |
| Physician Assessment of Spasticity | The physician assessed spasticity as per local standard practice. Not enough data was collected for analysis of this outcome measure. | Month 12 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with diagnosis of spasticity are selected from rehabilitation departments within the Spanish health system.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Director | Allergan | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mataró | Barcelona | Spain |
This was a retrospective chart review in patients with spasticity in the Spanish population.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | All Participants | This was a retrospective chart review in patients with spasticity in the Spanish population. There was no treatment in this study. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | All Participants | This was a retrospective chart review in patients with spasticity in the Spanish population. There was no treatment in this study. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Customized | Number |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Physician Assessment of Spasticity | The physician assessed spasticity as per local standard practice. Not enough data was collected for analysis of this outcome measure. | Planned analysis: All participants. Not enough data was collected for analysis of this outcome measure. | Posted | Baseline |
|
|
Not provided
Adverse Events were not collected/assessed for this study.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | All Participants | This was a retrospective chart review in patients with spasticity in the Spanish population. There was no treatment in this study. |
Not provided
Not provided
Not enough data was collected for analysis of Physician's Assessment of Spasticity outcome measures.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Vice President Medical Affairs, | Allergan, Inc | 714-246-4500 | clinicaltrials@allergan.com |
Not provided
| ID | Term |
|---|---|
| D009128 | Muscle Spasticity |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D009122 | Muscle Hypertonia |
| D020879 | Neuromuscular Manifestations |
Not provided
Not provided
Not provided
Not provided
Not provided
| Participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Primary | Physician Assessment of Spasticity | The physician assessed spasticity as per local standard practice. Not enough data was collected for analysis of this outcome measure. | Planned analysis: All participants. Not enough data was collected for analysis of this outcome measure. | Posted | Month 12 |
|
|
| 0 |
| 0 |
| 0 |
| 0 |
A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |